- Article
Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis
- Alexander A. Stepanov,
- Kristina A. Malsagova,
- Arthur T. Kopylov,
- Vladimir R. Rudnev,
- Dmitry E. Karateev,
- Evgenia I. Markelova,
- Elena L. Luchikhina,
- Elena E. Borisova and
- Anna L. Kaysheva
Reduction in tumor necrosis factor (αTNF) and interleukin-6 (IL-6) activities is a widely utilized strategy for the treatment of rheumatoid arthritis (RA) with a high success rate. Despite both schemes targeting the deprivation of inflammatory...

